Walleye Capital’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-1,997
| Closed | -$55.9K | – | 2844 |
|
2023
Q4 | $55.9K | Sell |
1,997
-3,091
| -61% | -$86.6K | ﹤0.01% | 1680 |
|
2023
Q3 | $242K | Buy |
+5,088
| New | +$242K | ﹤0.01% | 1417 |
|
2023
Q2 | – | Sell |
-18,116
| Closed | -$2.05M | – | 2536 |
|
2023
Q1 | $2.05M | Buy |
18,116
+17,708
| +4,340% | +$2.01M | 0.03% | 512 |
|
2022
Q4 | $45.7K | Buy |
+408
| New | +$45.7K | ﹤0.01% | 1624 |
|
2022
Q3 | – | Sell |
-4,998
| Closed | -$343K | – | 2550 |
|
2022
Q2 | $343K | Buy |
+4,998
| New | +$343K | 0.01% | 1205 |
|
2021
Q4 | – | Sell |
-10,883
| Closed | -$1.52K | – | 2168 |
|
2021
Q3 | $1.52K | Buy |
+10,883
| New | +$1.52K | 0.04% | 286 |
|
2019
Q3 | – | Sell |
-1,414
| Closed | -$91K | – | 786 |
|
2019
Q2 | $91K | Buy |
+1,414
| New | +$91K | 0.01% | 267 |
|